Nimbex and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nimbex (cisatracurium besylate) and Ranitidine (ranitidine). Common drug interactions include groin pain among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Nimbex and Ranitidine. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Nimbex?

Nimbex has active ingredients of cisatracurium besylate. eHealthMe is studying from 1,546 Nimbex users. Check the latest studies of Nimbex.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.



On Jul, 05, 2026

27 people who take Nimbex and Ranitidine together, and have interactions are studied.

Nimbex and Ranitidine drug interactions.

What are the common drug interactions of Nimbex and Ranitidine, by gender? *:

female:

  1. Groin pain
  2. Haematuria (presence of blood in urine)
  3. Haematuria present (presence of blood in urine due to trauma)
  4. Haemorrhage intracranial (bleeding within the skull)
  5. Hallucination, auditory (perceiving sounds without auditory stimulus)
  6. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  7. Hepatic cyst
  8. Hepatic failure (liver failure)
  9. Hepatitis acute
  10. Histiocytosis haematophagic

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Multi-organ failure (multisystem organ failure)
  3. Ventricular fibrillation (abnormally irregular heart rhythm)
  4. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  5. Abdominal pain
  6. Acute respiratory distress syndrome
  7. Anaemia (lack of blood)
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Anxiety
  10. B-cell lymphoma (blood cancer affecting b cells)

What are the common drug interactions of Nimbex and Ranitidine, by age (0-1 to 60+)? *:

0-1:

  1. Abdominal compartment syndrome (increased pressure in abdomen)
  2. Acute respiratory distress syndrome
  3. Ascites (accumulation of fluid in the abdominal cavity)
  4. Blood lactic acid increased
  5. Cholecystitis (infection of gallbladder)
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Drug ineffective
  9. Duodenal perforation (complication of duodenal ulcer)
  10. Enterococcal infection

2-9:

n/a

10-19:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Cerebral venous thrombosis (clot in brains venous blood system)
  3. Coagulopathy (blood's ability to clot is impaired)
  4. Asthenia (weakness)
  5. Autoimmune hepatitis
  6. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  7. Multi-organ failure (multisystem organ failure)
  8. Muscle necrosis (muscle cell damage)
  9. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  10. Myopathy (a muscular disease in which the muscle fibres do not function)

20-29:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood alkaline phosphatase increased
  4. Cystic hygroma (abnormal growths that usually appear on a baby's neck or head)
  5. Depressed level of consciousness
  6. Gamma-glutamyltransferase increased
  7. Hepatic infarction (particular area of the liver has lost its blood supply and died)
  8. Hepatitis acute
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Hypotension (abnormally low blood pressure)

30-39:

  1. Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
  2. Post procedural complication
  3. Pulmonary congestion (congestion in the lungs)
  4. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Respiratory rate increased (excess breathing rate/min)
  7. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  8. Sudden death
  9. Cardiogenic shock (inadequate circulation of blood)
  10. Drug hypersensitivity

40-49:

  1. Abdominal pain
  2. Anaemia (lack of blood)
  3. B-cell lymphoma (blood cancer affecting b cells)
  4. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  5. Constipation
  6. Crystalluria (crystals found in the urine)
  7. Cytomegalovirus infection
  8. Eating disorder
  9. Haematuria (presence of blood in urine)
  10. Impaired healing

50-59:

  1. Abdominal distension
  2. Abdominal pain
  3. Abdominal pain upper
  4. Adrenal mass
  5. Agitation (state of anxiety or nervous excitement)
  6. Back pain
  7. Brain death
  8. Chest pain
  9. Deafness unilateral
  10. Dementia (madness)

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Renal failure (kidney dysfunction)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Blood amylase increased
  6. Blood creatinine increased
  7. Body temperature increased
  8. Confusional state
  9. Death
  10. Emotional distress

What are the existing conditions these people have? *

  1. Pain: 2 people, 7.41%
  2. Neuromuscular Blockade: 2 people, 7.41%
  3. Birth Control: 2 people, 7.41%
  4. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Nimbex and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nimbex and Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nimbex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nimbex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cisatracurium besylate and ranitidine (the active ingredients of Nimbex and Ranitidine, respectively), and Nimbex and Ranitidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: